成都爱迪眼科医院 is a national level three eye hospital that focuses on various eye diseases and corrective procedures.

成都爱迪眼科医院

Alcon focuses on the innovation of vision products that aim to improve people's lives.

Alcon

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Bernard Chauvin

Bausch + Lomb Corporation

Gaush Meditech Ltd., together with its subsidiaries, researches and develops, produces, and sells ophthalmic medical devices in the People's Republic of China and internationally. The company operates through Proprietary Products, Distribution, Technical, and Others segments. Its ophthalmic medical devices are used for diagnosis, treatment, or surgeries, including vitreoretinal diseases, cataract, glaucoma, refractive surgery, ocular surface diseases, optometry, and pediatric ophthalmology. The Proprietary Products segment develops and produces surgical equipment and related supporting software, intra optical lens, and ophthalmic disease diagnosis and treatment equipment and related supporting consumables. The Distribution segment sells diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment, and related supporting consumables. The Technical segment provides warranty services, maintenance services, and after-sales services related consumables. The Others segment engages in the provision of equipment leasing and agent registration services; and licensing intellectual properties. The company sells its products directly and through distributors to public and private hospitals, and other customers. Gaush Meditech Ltd. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.

Gaush Meditech Ltd

成都爱迪眼科医院 is a national Grade III Class A ophthalmology hospital in Chengdu, offering various eye care services.

成都爱迪眼科医院有限公司 | 3 followers on LinkedIn. 

Metric
Company Name	成都爱迪眼科医院	Alcon	Bausch + Lomb Corporation	Gaush Meditech Ltd
Symbol			BLCO	2.41K
MSH ID	COM:028AIDI	CN:COM:ALCON	COM:BAUSCH	COM:GAUSH
Market	PRIVATE	PRIVATE	STOCKS	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare
Industry	Healthcare	Medical Devices	Medical - Instruments & Supplies
Country	CN	CN	CA	CN
Stage
Employee Count			13.30K	869
Website	028aidi.com	alcon.com.cn	bausch.com	gaush.com
LinkedIn	%E6%88%90%E9%83%BD%E7%88%B1%E8%BF%AA%E7%9C%BC%E7%A7%91%E5%8C%BB%E9%99%A2%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8
Founders

Metric
Market Cap	5.43B	217.58M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	4.15B	193.42M
Revenue (LTM)
Revenue (NTM)
Gross Profit	2.50B	95.13M
EBITDA	601M	50.91M
Operating Income	130M	40.46M
Net Income	-260M	23.87M
EPS	-0.74	0.16
Diluted EPS	-0.74	0.16
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.96	0.49
Operating Profit Margin	0.12	0.21
EBITDA Margin	0.14	0.26
Net Profit Margin	-0.00	0.12
Return on Equity	0.02	0.11
Return on Assets	-0.00	0.06
Return on Capital Employed	0.05	0.15

028A

COM:028AIDI

成都爱迪眼科医院

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-23.54
P/B Ratio	0.71
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.64	1.65
EV Multiple	17.67	7.70

Metric
Days Sales Outstanding	72.01
Days Payables Outstanding	82.99	46.26
Days Inventory Outstanding	1.62K	218.38
Operating Cycle	1.70K	269.92
Cash Conversion Cycle	1.07K	209.72
Asset Turnover	0.34	0.49

Metric
Operating Cash Flow	-17M	34.25M
Free Cash Flow	-198M	27.98M
Cash Flow to Debt	0.05	0.37
Operating Cash Flow/Sales	0.13	0.18
Free Cash Flow Yield	-0.00	0.14

Metric
Cash & Equivalents	331M	85.10M
Accounts Receivable	-121M	2.71M
Inventory	1.03B	45.19M
Goodwill	4.58B	132.24M
Debt to Capitalization	1.05	0.28
Debt to Assets	0.34	0.23
Current Ratio	1.78	1.56
Quick Ratio	1.03	1.38

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.02
R&D to Revenue	0.08	0.04
SG&A to Revenue		0.09